Dextromethorphan hydrobromide 4 MG/ML / phenylephrine hydrochloride 2 MG/ML / triprolidine... — RxCUI 1492052
RxNorm drug concept · Semantic clinical drug
RxCUI 1492052
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1492052
Official nameDextromethorphan hydrobromide 4 MG/ML / phenylephrine hydrochloride 2 MG/ML / triprolidine hydrochloride 0.5 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdextromethorphan hydrobromide 20 MG / phenylephrine hydrochloride 10 MG / triprolidine hydrochloride 2.5 MG per 5 ML Oral Solution; dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG / triprolidine HCl 2.5 MG in 5 mL Oral Solution
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)13,020 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Phenylephrine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Yes, it's the same active ingredient, but used in very different ways depending on the form. The nasal spray delivers a tiny amount directly to the nasal lining to temporarily shri...
- I see phenylephrine in nasal sprays at the pharmacy AND as an IV drug in the hospital — is it really the same medication?
- You should check with your doctor first. Phenylephrine constricts blood vessels, which can raise blood pressure and put extra strain on the heart — even from a nasal spray. If you...
- Can I use the nasal spray if I have high blood pressure or heart disease?
🕸️ Concept Web — How Dextromethorphan hydrobromide 4 MG/ML / phenylep... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Dextromethorphan hydrobromide 4 MG/ML / phenylephrine hydrochloride 2 MG/ML / triprolidine hydrochloride 0.5 MG/ML Oral Solution
RxCUI 1492052 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 7
The active substance itself — no strength, form, or brand attached yet.
-
Dextromethorphan
3289IN -
Phenylephrine
8163IN -
Triprolidine
10849IN -
Dextromethorphan / phenylephrine / triprolidine
1492051MIN -
Dextromethorphan hydrobromide
102490PIN -
Phenylephrine hydrochloride
8164PIN -
Triprolidine hydrochloride
71534PIN
-
Dextromethorphan
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dextromethorphan / phenylephrine / triprolidine Oral Solution
1492050SCDF -
Dextromethorphan hydrobromide / phenylephrine hydrochloride / triprolidine hydrochloride Oral Solution
2648202SCDFP -
Dextromethorphan / phenylephrine / triprolidine Oral Liquid Product
1492048SCDG -
Dextromethorphan / phenylephrine / triprolidine Oral Product
1492049SCDG -
Dextromethorphan hydrobromide / phenylephrine hydrochloride / triprolidine hydrochloride Oral Liquid Product
2661520SCDGP -
Dextromethorphan hydrobromide / phenylephrine hydrochloride / triprolidine hydrochloride Oral Product
2661165SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Dextromethorphan / phenylephrine / triprolidine Oral Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dextromethorphan hydrobromide 4 MG/ML
1010978SCDC -
Phenylephrine hydrochloride 2 MG/ML
996626SCDC -
Triprolidine hydrochloride 0.5 MG/ML
1094403SCDC
-
Dextromethorphan hydrobromide 4 MG/ML
Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dextromethorphan hydrobromide 4 MG/ML
SCDC · 1010978 -
Phenylephrine hydrochloride 2 MG/ML
SCDC · 996626 -
Triprolidine hydrochloride 0.5 MG/ML
SCDC · 1094403 -
Dextromethorphan / phenylephrine / triprolidine Oral Solution
SCDF · 1492050 -
Dextromethorphan hydrobromide / phenylephrine hydrochloride / triprolidine hydrochloride Oral Solution
SCDFP · 2648202 -
Dextromethorphan / phenylephrine / triprolidine Oral Liquid Product
SCDG · 1492048 -
Dextromethorphan / phenylephrine / triprolidine Oral Product
SCDG · 1492049 -
Dextromethorphan hydrobromide / phenylephrine hydrochloride / triprolidine hydrochloride Oral Liquid Product
SCDGP · 2661520 -
Dextromethorphan hydrobromide / phenylephrine hydrochloride / triprolidine hydrochloride Oral Product
SCDGP · 2661165
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 1492052 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 28595-0804-16 | 473 mL in 1 BOTTLE (28595-804-16) | HISTEX-DM | Allegis Pharmaceuticals, LLC | 2014-03-19 |
Observed labelers:
Allegis Pharmaceuticals, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.0739
Range $0.0739–$0.0739
· middle 50% $0.0739–$0.0739
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.